Bioceres Reports Q3 2026 Earnings with Declining Revenue and Net Loss
Bioceres (BIOX) reported a net loss of $10 million for Q3 2026, driven by lower gross profit and increased financial expenses. Total revenue fell to $39.4 million, down 23%, primarily due to the Pro Farm foreclosure and seasonal weakness.
Topics: debt litigation net loss revenue decline segment performance